Time-varying serum albumin levels and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study

• Main Authors: Na Hao, Ben-Chung Cheng, Hong-Tao Yang, Chien-Hsing Wu, Yang-Yang Lei, Mei-Chen Chao, Pei-Ying Wang, Li-Chueh Kuo, Sin-Hua Moi, Cheng-Hong Yang, Jin-Bor Chen
• Format: Article
• Language: English
• Published: BMC 2019-07-01
• Series: BMC Nephrology
• Subjects: Albumin; Mortality; Peritoneal dialysis
• Online Access: http://link.springer.com/article/10.1186/s12882-019-1433-8

Abstract Background In this study, we investigated the association of time-varying serum albumin levels with mortality over a 5-year period in one cohort of patients undergoing long-term peritoneal dialysis (PD) therapy. Methods The participants in this study enrolled 302 patients who underwent long-term PD at a single PD center in Taiwan. We reviewed medical records from 2011 to 2015 retrospectively. Time-averaged albumin level and serum albumin reach rate (defined as the percentage of serum albumin measurements that reached ≥3.5 g/dL) were applied as the predictor variables in the first 2 years (2011–2012). All-cause mortality was used as the outcome variable in the subsequent 3 years (2013–2015). Hazard function of all-cause mortality in the study participants was examined by using Cox proportional hazard regression models . Results Patients with different albumin reach rates (75–< 100%, 50–< 75%, 1–< 50%) did not exhibit a significantly increased risk for all-cause mortality. Patients with a 0% albumin reach rate exhibited a significantly increased risk for all-cause mortality (hazard ratio [HR] 7.59, 95% confidence interval [CI], 2.38–24.21) by fully adjusted analysis. Patients with time-averaged albumin levels of < 3.5 g/dL (HR 15.49, 95% CI 1.74–137.72) exhibited a higher risk for all-cause mortality than those with serum albumin levels ≥4.0 g/dL. Conclusions This study demonstrated that higher serum albumin reach rates and higher time-averaged serum albumin levels are associated with a lower mortality rate over a 5-year period among patients undergoing long-term PD.